Literature DB >> 10890623

Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis.

G A Dempsey1, H J Lyall, C F Corke, C D Scheinkestel.   

Abstract

OBJECTIVE: To report four cases of pyroglutamic acidemia in adults causing clinically significant acidosis. DATA SOURCES: Patients admitted to the intensive care units of the Alfred Hospital (a quaternary referral center) and Geelong Hospital (a major regional center) with an unexplained high anion gap acidosis.
CONCLUSIONS: Pyroglutamic acidemia (5-oxoprolinemia) is a rare cause of high anion gap metabolic acidosis that should be suspected in patients presenting with sepsis, hepatic, and/or renal dysfunction who are receiving drugs such as acetaminophen, flucloxacillin, and vigabatrin after the more common causes of a high anion gap acidosis have been excluded. Should pyroglutamic aciduria be present, known precipitants should be ceased, infection should be managed aggressively, and supportive management should be instituted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10890623     DOI: 10.1097/00003246-200006000-00018

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  17 in total

1.  Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: an under diagnosed phenomenon.

Authors:  L Morgan Nordstrom O'Brien; Michael Hooper; Mark Flemmer; Paul Ellis Marik
Journal:  BMJ Case Rep       Date:  2012-07-03

2.  Refractory metabolic acidosis in patients with sepsis following hemiarthroplasty for femoral neck fracture: a causative role for paracetamol and flucloxacillin?

Authors:  Halima Amer; Frances Dockery; Nicholas Barrett; Marc George; Karolina Witek; Jeremy Stanton; Diane Back
Journal:  BMJ Case Rep       Date:  2011-07-20

3.  Understanding lactic acidosis in paracetamol (acetaminophen) poisoning.

Authors:  Anoop D Shah; David M Wood; Paul I Dargan
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

4.  Lesson of the month 1: A rare adverse reaction between flucloxacillin and paracetamol.

Authors:  William Osborne; Aneeka Chavda; George Katritsis; Jon S Friedland
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

5.  Unexplained metabolic acidosis in critically ill patients: the role of pyroglutamic acid.

Authors:  Barry A Mizock; Stanislav Belyaev; Carter Mecher
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

Review 6.  Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle.

Authors:  Michael Emmett
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

7.  Profound metabolic acidosis and oxoprolinuria in an adult.

Authors:  Michael J Hodgman; James F Horn; Christine M Stork; Jeanna M Marraffa; Michael G Holland; Richard Cantor; Patti M Carmel
Journal:  J Med Toxicol       Date:  2007-09

8.  Transient 5-oxoprolinuria: unusually high anion gap acidosis in an infant.

Authors:  Sarah L Hulley; Jeff Perring; Nigel Manning; Simon Olpin; Sufin Yap
Journal:  Eur J Pediatr       Date:  2015-07-01       Impact factor: 3.183

Review 9.  Unmeasured anions in metabolic acidosis: unravelling the mystery.

Authors:  Lui G Forni; William McKinnon; Philip J Hilton
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 10.  Translational biomarkers of acetaminophen-induced acute liver injury.

Authors:  Richard D Beger; Sudeepa Bhattacharyya; Xi Yang; Pritmohinder S Gill; Laura K Schnackenberg; Jinchun Sun; Laura P James
Journal:  Arch Toxicol       Date:  2015-05-17       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.